ZILA INC
10-Q, EX-27, 2000-06-14
PHARMACEUTICAL PREPARATIONS
Previous: ZILA INC, 10-Q, 2000-06-14
Next: FASTCOMM COMMUNICATIONS CORP, 8-K/A, 2000-06-14



<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          JUL-31-1999
<PERIOD-END>                               APR-30-2000
<CASH>                                       4,334,707
<SECURITIES>                                         0
<RECEIVABLES>                               11,242,976
<ALLOWANCES>                                 (338,248)
<INVENTORY>                                 11,790,091
<CURRENT-ASSETS>                            29,793,353
<PP&E>                                      10,849,260
<DEPRECIATION>                             (4,287,503)
<TOTAL-ASSETS>                              73,808,274
<CURRENT-LIABILITIES>                        8,538,986
<BONDS>                                      4,977,046
                                0
                                          0
<COMMON>                                        43,330
<OTHER-SE>                                  60,248,912
<TOTAL-LIABILITY-AND-EQUITY>                73,808,274
<SALES>                                     58,735,750
<TOTAL-REVENUES>                            58,811,167
<CGS>                                       29,678,102
<TOTAL-COSTS>                               29,514,850
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             192,274
<INCOME-PRETAX>                              4,347,453
<INCOME-TAX>                               (2,418,170)
<INCOME-CONTINUING>                          1,929,283
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 1,929,283
<EPS-BASIC>                                       0.05
<EPS-DILUTED>                                     0.05


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission